000 | 01800 a2200481 4500 | ||
---|---|---|---|
005 | 20250516170718.0 | ||
264 | 0 | _c20140127 | |
008 | 201401s 0 0 eng d | ||
022 | _a1529-0131 | ||
024 | 7 |
_a10.1002/art.38180 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRayavarapu, Sree | |
245 | 0 | 0 |
_aActivation of the ubiquitin proteasome pathway in a mouse model of inflammatory myopathy: a potential therapeutic target. _h[electronic resource] |
260 |
_bArthritis and rheumatism _cDec 2013 |
||
300 |
_a3248-58 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBoronic Acids _xpharmacology |
650 | 0 | 4 | _aBortezomib |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aEndoplasmic Reticulum Stress _xdrug effects |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aMuscle Weakness _xmetabolism |
650 | 0 | 4 |
_aMuscle, Skeletal _xdrug effects |
650 | 0 | 4 |
_aMyositis _xmetabolism |
650 | 0 | 4 |
_aProteasome Endopeptidase Complex _xmetabolism |
650 | 0 | 4 |
_aProteasome Inhibitors _xpharmacology |
650 | 0 | 4 |
_aPyrazines _xpharmacology |
650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
650 | 0 | 4 |
_aUbiquitin _xmetabolism |
650 | 0 | 4 |
_aUbiquitination _xdrug effects |
700 | 1 | _aColey, William | |
700 | 1 | _aVan der Meulen, Jack H | |
700 | 1 | _aCakir, Erdinc | |
700 | 1 | _aTappeta, Kathyayini | |
700 | 1 | _aKinder, Travis B | |
700 | 1 | _aDillingham, Blythe C | |
700 | 1 | _aBrown, Kristy J | |
700 | 1 | _aHathout, Yetrib | |
700 | 1 | _aNagaraju, Kanneboyina | |
773 | 0 |
_tArthritis and rheumatism _gvol. 65 _gno. 12 _gp. 3248-58 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/art.38180 _zAvailable from publisher's website |
999 |
_c23075708 _d23075708 |